ROQO_PENRW
ID ROQO_PENRW Reviewed; 503 AA.
AC B6HJU3;
DT 08-JUN-2016, integrated into UniProtKB/Swiss-Prot.
DT 16-DEC-2008, sequence version 1.
DT 03-AUG-2022, entry version 77.
DE RecName: Full=Cytochrome P450 monooxygenase roqO {ECO:0000305};
DE EC=1.-.-.- {ECO:0000269|PubMed:22118684, ECO:0000269|PubMed:23776469, ECO:0000269|PubMed:24225953};
DE AltName: Full=Roquefortine/meleagrin synthesis protein O {ECO:0000303|PubMed:23776469};
GN Name=roqO {ECO:0000303|PubMed:23776469}; ORFNames=Pc21g15450;
OS Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin
OS 54-1255) (Penicillium chrysogenum).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Penicillium;
OC Penicillium chrysogenum species complex.
OX NCBI_TaxID=500485;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255;
RX PubMed=18820685; DOI=10.1038/nbt.1498;
RA van den Berg M.A., Albang R., Albermann K., Badger J.H., Daran J.-M.,
RA Driessen A.J.M., Garcia-Estrada C., Fedorova N.D., Harris D.M.,
RA Heijne W.H.M., Joardar V.S., Kiel J.A.K.W., Kovalchuk A., Martin J.F.,
RA Nierman W.C., Nijland J.G., Pronk J.T., Roubos J.A., van der Klei I.J.,
RA van Peij N.N.M.E., Veenhuis M., von Doehren H., Wagner C., Wortman J.R.,
RA Bovenberg R.A.L.;
RT "Genome sequencing and analysis of the filamentous fungus Penicillium
RT chrysogenum.";
RL Nat. Biotechnol. 26:1161-1168(2008).
RN [2]
RP FUNCTION.
RX PubMed=22118684; DOI=10.1016/j.chembiol.2011.08.012;
RA Garcia-Estrada C., Ullan R.V., Albillos S.M., Fernandez-Bodega M.A.,
RA Durek P., von Doehren H., Martin J.F.;
RT "A single cluster of coregulated genes encodes the biosynthesis of the
RT mycotoxins roquefortine C and meleagrin in Penicillium chrysogenum.";
RL Chem. Biol. 18:1499-1512(2011).
RN [3]
RP FUNCTION, AND CATALYTIC ACTIVITY.
RX PubMed=24225953; DOI=10.1074/jbc.m113.512665;
RA Ries M.I., Ali H., Lankhorst P.P., Hankemeier T., Bovenberg R.A.,
RA Driessen A.J., Vreeken R.J.;
RT "Novel key metabolites reveal further branching of the
RT roquefortine/meleagrin biosynthetic pathway.";
RL J. Biol. Chem. 288:37289-37295(2013).
RN [4]
RP FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND DISRUPTION PHENOTYPE.
RX PubMed=23776469; DOI=10.1371/journal.pone.0065328;
RA Ali H., Ries M.I., Nijland J.G., Lankhorst P.P., Hankemeier T.,
RA Bovenberg R.A., Vreeken R.J., Driessen A.J.;
RT "A branched biosynthetic pathway is involved in production of roquefortine
RT and related compounds in Penicillium chrysogenum.";
RL PLoS ONE 8:E65328-E65328(2013).
RN [5]
RP BIOTECHNOLOGY.
RX PubMed=26692349; DOI=10.1016/j.bmc.2015.11.038;
RA Mady M.S., Mohyeldin M.M., Ebrahim H.Y., Elsayed H.E., Houssen W.E.,
RA Haggag E.G., Soliman R.F., El Sayed K.A.;
RT "The indole alkaloid meleagrin, from the olive tree endophytic fungus
RT Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent
RT breast cancer proliferation, migration and invasion.";
RL Bioorg. Med. Chem. 24:113-122(2016).
CC -!- FUNCTION: Cytochrome P450 monooxygenase; part of the gene cluster that
CC mediates the biosynthesis of the mycotoxin meleagrin (PubMed:22118684,
CC PubMed:23776469). The first stage is catalyzed by the dipeptide
CC synthase roqA which condenses histidine and tryptophan to produce
CC histidyltryptophanyldiketopiperazine (HTD) (PubMed:22118684,
CC PubMed:23776469). HTD is then converted to roquefortine C through two
CC possible pathways (PubMed:23776469). In the first pathway,
CC prenyltransferase roqD transforms HTD to the intermediate roquefortine
CC D, which is in turn converted to roquefortine C by the cytochrome P450
CC monooxygenase roqR (PubMed:23776469). In the second pathway, HTD is
CC first converted to the intermediate dehydrohistidyltryptophanyldi-
CC ketopiperazine (DHTD) by roqR which is then prenylated by roqD to form
CC roquefortine C (PubMed:23776469). Roquefortine C can be further
CC transformed to meleagrin via three more reactions including oxydation
CC to glandicolin A by roqM, which is further reduced to glandicoline B by
CC roqO (PubMed:23776469). Finally, glandicoline B is converted to
CC meleagrin by the glandicoline B O-methyltransferase roqN
CC (PubMed:22118684, PubMed:23776469). More studies identified further
CC branching and additional metabolites produced by the
CC roquefortine/meleagrin cluster, including roquefortine F, roquefortine
CC L, roquefortine M, roquefortine N and neoxaline (PubMed:24225953).
CC {ECO:0000269|PubMed:22118684, ECO:0000269|PubMed:23776469,
CC ECO:0000269|PubMed:24225953}.
CC -!- COFACTOR:
CC Name=heme; Xref=ChEBI:CHEBI:30413;
CC Evidence={ECO:0000250|UniProtKB:P04798};
CC -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:22118684,
CC ECO:0000269|PubMed:23776469, ECO:0000269|PubMed:24225953}.
CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane
CC protein {ECO:0000255}.
CC -!- INDUCTION: Expression is decreased in presence of phenylacetic acid
CC (PAA) (PubMed:23776469). {ECO:0000269|PubMed:23776469}.
CC -!- DISRUPTION PHENOTYPE: Impairs the production of glandicoline B and
CC meleagrin (PubMed:23776469). {ECO:0000269|PubMed:23776469}.
CC -!- BIOTECHNOLOGY: The indole alkaloid meleagrin was shown to be a good
CC candidate to control c-Met-dependent breast cancer proliferation,
CC migration and invasion (PubMed:26692349).
CC {ECO:0000269|PubMed:26692349}.
CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AM920436; CAP96442.1; -; Genomic_DNA.
DR RefSeq; XP_002568555.1; XM_002568509.1.
DR AlphaFoldDB; B6HJU3; -.
DR SMR; B6HJU3; -.
DR STRING; 1108849.XP_002568555.1; -.
DR EnsemblFungi; CAP96442; CAP96442; PCH_Pc21g15450.
DR GeneID; 8315546; -.
DR KEGG; pcs:Pc21g15450; -.
DR VEuPathDB; FungiDB:PCH_Pc21g15450; -.
DR eggNOG; KOG0157; Eukaryota.
DR HOGENOM; CLU_022195_0_3_1; -.
DR OMA; RICEHPE; -.
DR OrthoDB; 614788at2759; -.
DR BioCyc; PCHR:PC21G15450-MON; -.
DR Proteomes; UP000000724; Contig Pc00c21.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0020037; F:heme binding; IEA:InterPro.
DR GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR GO; GO:0008152; P:metabolic process; IEA:UniProt.
DR Gene3D; 1.10.630.10; -; 1.
DR InterPro; IPR001128; Cyt_P450.
DR InterPro; IPR017972; Cyt_P450_CS.
DR InterPro; IPR002403; Cyt_P450_E_grp-IV.
DR InterPro; IPR036396; Cyt_P450_sf.
DR Pfam; PF00067; p450; 1.
DR PRINTS; PR00465; EP450IV.
DR SUPFAM; SSF48264; SSF48264; 1.
DR PROSITE; PS00086; CYTOCHROME_P450; 1.
PE 1: Evidence at protein level;
KW Glycoprotein; Heme; Iron; Membrane; Metal-binding; Monooxygenase;
KW Oxidoreductase; Reference proteome; Transmembrane; Transmembrane helix.
FT CHAIN 1..503
FT /note="Cytochrome P450 monooxygenase roqO"
FT /id="PRO_0000436347"
FT TRANSMEM 11..31
FT /note="Helical"
FT /evidence="ECO:0000255"
FT BINDING 444
FT /ligand="heme"
FT /ligand_id="ChEBI:CHEBI:30413"
FT /ligand_part="Fe"
FT /ligand_part_id="ChEBI:CHEBI:18248"
FT /note="axial binding residue"
FT /evidence="ECO:0000250|UniProtKB:P04798"
FT CARBOHYD 205
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ SEQUENCE 503 AA; 57477 MW; CC4012842D407006 CRC64;
MDVVARFMVS YSGTACAISL FIFGITLLFP FHKSQSFVCM NSHSWDIFRN KAKREFESNA
EKLIKDALRK GLTAFQLVTN MGTYLILADQ YAEELRNDKR LSAYDALNDV ILLELPGLET
MFQGSLHNHV SPTAIHAMNR ELVHLTRALS DEANHRLQTQ WTDSSEWHTV SIHDTVLALV
AQMTTRAFVG AELCRNAEWL DIAINFTINR AIAVQAVQAW PWILQPVVHW FLPTCKAVRR
QIQRARTILM PVLERERQTM HRKDSSSDRI FSTLTFIDQY AQGSRYDATM AQLRLTAVSV
LTTSDMVEKV LARICEHPEL IQPLREEVVS VFESSGLHHK SLLKLTLMES VMKESQRLEP
ATLISMFRAA KKTVTLQDGT TIPKGTRLAF ANDLRLDPEL YPDPETFDGY RFERMRKDPE
QAKLAPFTKT RTSHLAFGHG KHACPGRFLS CDEAKLILCH ILLKYDFKAL DGRVPDLHVR
SMFIQRDTGG MLSVRRRQEE VTL